Walgreens Boots Alliance (NASDAQ:WBA) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Walgreens Boots Alliance (NASDAQ:WBA) announced its quarterly earnings results on Tuesday. The pharmacy operator reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03, Briefing.com reports. The firm had revenue of $37.50 billion during the quarter, compared to analysts’ expectations of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company’s revenue was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.67 EPS. Walgreens Boots Alliance updated its FY 2025 guidance to 1.400-1.800 EPS and its FY25 guidance to $1.40-$1.80 EPS.

Walgreens Boots Alliance Trading Up 6.2 %

Shares of Walgreens Boots Alliance stock opened at $11.07 on Thursday. The firm’s 50 day simple moving average is $9.41 and its two-hundred day simple moving average is $13.22. The firm has a market capitalization of $9.56 billion, a price-to-earnings ratio of -1.64, a PEG ratio of 1.06 and a beta of 0.70. Walgreens Boots Alliance has a 12-month low of $8.22 and a 12-month high of $27.05. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on WBA shares. JPMorgan Chase & Co. dropped their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research note on Monday, October 7th. Royal Bank of Canada cut their target price on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a research note on Tuesday, July 2nd. Morgan Stanley reduced their target price on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. Finally, Evercore ISI raised their price target on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a report on Wednesday. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus price target of $13.54.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.